Amgen Inc. Accounts Payable for the year ending December 31, 2024: USD 1.91 B

Amgen Inc. Accounts Payable is USD 1.91 B for the year ending December 31, 2024, a 20.00% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Amgen Inc. Accounts Payable for the year ending December 31, 2023 was USD 1.59 B, a 1.15% change year over year.
  • Amgen Inc. Accounts Payable for the year ending December 31, 2022 was USD 1.57 B, a 15.08% change year over year.
  • Amgen Inc. Accounts Payable for the year ending December 31, 2021 was USD 1.37 B, a -3.87% change year over year.
  • Amgen Inc. Accounts Payable for the year ending December 31, 2020 was USD 1.42 B, a 3.65% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities